OpenLB
Open Library of Bioscience
Advanced Search
Journal of clinical medicine
Feb 26, 2023;12 (5):

COVID-19 and Biomarkers: The Contribution of the Journal.

Mario Plebani
Author Information
  1. Mario Plebani: Clinical Biochemistry and Clinical Molecular Biology, University of Padova, 35122 Padova, Italy. ORCID
PMID: 36902640 DOI: 10.3390/jcm12051853

Abstract

Three years after coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO), several features of the pathogenesis and innate immune response to SARS-CoV-2 (severe acute respiratory syndrome coronavirus disease 2) have now been clarified [...].

References

  1. Biochem Biophys Res Commun. 1993 Apr 30;192(2):553-60 [PMID: 8387282]
  2. Clin Chem. 2005 Oct;51(10):1823-9 [PMID: 16099941]
  3. J Clin Med. 2021 Aug 11;10(16): [PMID: 34441830]
  4. J Clin Med. 2021 Apr 16;10(8): [PMID: 33923719]
  5. Clin Chem. 1998 Mar;44(3):571-7 [PMID: 9510864]
  6. Clin Chim Acta. 1999 Sep;287(1-2):131-43 [PMID: 10509902]
  7. Haematologica. 2021 Sep 01;106(9):2493-2498 [PMID: 33832219]
  8. Arq Bras Cardiol. 2016 Feb;106(2):145-52 [PMID: 26761075]
  9. J Appl Lab Med. 2017 Sep 1;2(2):222-233 [PMID: 32630976]
  10. Shock. 1998 Nov;10(5):383-4 [PMID: 9840656]
  11. J Clin Med. 2022 Mar 24;11(7): [PMID: 35407410]
  12. J Clin Med. 2021 Apr 13;10(8): [PMID: 33924637]
Editorial

Word Cloud

Created with Highcharts 10.0.0coronavirusdiseaseCOVID-19Threeyears2019declaredpandemicWorldHealthOrganizationWHOseveralfeaturespathogenesisinnateimmuneresponseSARS-CoV-2severeacuterespiratorysyndrome2nowclarified[]Biomarkers:ContributionJournal

Similar Articles

Cited By